However, L3MBTL3 expression was downregulated in breast cancer (BRCA), cervical cancer (CESC), kidney chromophobe (KICH), Pheochromocytoma and Paraganglioma (PCPG), thyroid cancer (THCA), and uterine corpus endometrial carcinoma (UCEC) (Figure 1A). This evidence concerns the gene L3MBTL3 and cervical cancer.